Adequan Equine I.M. Multi-Dose, 100 mg/mL, 50 mL are joint relief medications used in aging and arthritic horses. I.M is an intramuscular injection for arthritis and joint pain in horses.
Adequan Equine provides relief from joint pain in horses suffering from arthritis, inflammation, and other degenerative joint diseases.
This horse medication manufactured by LUITPOLD PHARMACEUTICALS, INC., brings relief from joint pain in horses within hours and general improvements in 4 weeks. It also prevents cartilage breakdown.
Please note: This is a special order item that may require 10-14 days lead time before it is available for shipping.
You can get this horse medication for arthritis as well as other horse medicines and pet prescription medication from our online pet pharmacy. Our pet pharmacy online is based in Texas.
For Intramuscular Use In Horses Only. Not for Intra-Articular Use.
Federal law restricts this pet meds to use by or on the order of a licensed veterinarian.
This horse medication is a brand of Polysulfated Glycosaminoglycan (PSGAG)
Solution 100 mg/mL in 50 mL
Preserved Multi-Dose Vials
Each mL contains Polysulfated Glycosaminoglycan 100 mg, Benzyl Alcohol 0.9% v/v as a preservative, and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH.
Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes or reverses the pathologic processes of traumatic or degenerative joint disease which result in a net loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine carpal and hock joints in horses.
Adequan® i.m. Multi-Dose is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
DOSAGE AND ADMINISTRATION:
The recommended dose of Adequan® i.m. Multi-Dose in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix this horse medication with other drugs or solvents.
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan.
Do not use this pet med in horses intended for human consumption. Not for use in humans. Keep this and all horse medicines out of the reach of children.
The safe use of Adequan® i.m. Multi-Dose in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated.
SAFETY AND EFFICACY:
Safety and efficacy studies utilizing Adequan® i.m. Multi-Dose were not performed. This horse medication for arthritis was approved based on the conclusion that the safety and effectiveness of Adequan® i.m. Multi-Dose will not differ from that demonstrated for the original formulation of this horse medication.
Animal Safety studies utilizing Adequan® i.m. Multi-Dose were not performed. Safety studies were conducted in horses using the single dose formulation.
Doses as high as 2,500 mg, were administered intramuscularly to 6 horses twice a week for 12 weeks. This dosage of horse medication is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no soreness or swelling at the injection site or in the affected joint in arthritic horses.
No animal had any clinical or laboratory evidence of toxicity after using this pet meds.
Store this horse medication at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature). Dispose of spent needles in accordance with all federal, state and local environmental laws.
Adequan I.M. Multi-Dose solution, 100 mg/mL is available in 50 mL glass vials, packaged in boxes of 1.
LUITPOLD PHARMACEUTICALS, INC.,
Animal Health Division, Shirley, NY 11967
Made in U.S.A.
NADA #140-901, Approved by FDA